AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2022

Aug 24, 2022

32641_dirs_2022-08-23_fa86894e-9515-43b4-abeb-7f2b04ba84ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2022-08-20

Reporting Person: STIGALL L. JEREMY (GM, Biologics & Drug Delivery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-20	Common Stock	F	203	$13.24	Disposed	42692	Direct

Footnotes

F1: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

F2: Includes 1,369 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.